III. Matériels et méthodes
12] CHASTAGNER P, DOZ F
Cancer de l'enfant : particularité épidémiologiques, diagnostiques et thérapeutiques. Item 144 Campus National de pédiatrie et chirurgie pédiatrique TICEM – UMVF MAJ : 09/12/2005.
[13] Aguzzi, A., Brandner, S., Paulus, W., 2000. In: Kleihues, P., Cavenee, W.K. (Eds.)
Choroids plexus tumours: pathology and genetics of tumours of the nervous system. IARC Press, Lyon, pp. 83–86.
[14] Baskaya, M.K., Erekul, S., Egemen, N., Gokalp, H.Z., Sertcelik, A., 1994.
Choroid plexus carcinoma of the lateral ventricle: report of a case in an adult. Clin Neurol Neurosurg 96, 47–51.
[15] Cohen, M.E., Duffner, P.K., 1994.
Brain tumors in children: Principles of diagnosis and management, 2nd ed. Raven Press, New York, p. 371.
[16] Chow, E., Reardon, D.A., Shah, A.B., Jenkins, J.J., Langston, J., Heideman, R.L., et al., 1999.
Pediatric choroid plexus neoplasms. Int J Radiat Oncol Biol Phys 44, 249–254.
[17] Ellenbogen, R.G., Winston, R.K., Kupsky, W.J., 1989.
Tumors of the colloid plexus in children. Neurosurgery 25, 327–334. [18] Griffin, B.R., Stewart, G.R., Berger, M.S., Geyer, J.R., O’Dell, M.,
Rostad, S., 1988.
Choroid plexus carcinoma of the fourth ventricle. Report of a case in an infant. Pediatr Neurosci 14, 134–139.
[19] Kepes, J.J., Collins, J., 1999.
Choroid plexus epithelium (normal and neoplastic) expresses synaptophysin. A potentially useful aid in differentiating carcinoma of the choroid plexus from metastatic papillary carcinomas. J Neuropathol Exp Neurol 58, 398–401.
[20] Kim, K., Greenblatt, H., Robinson, M.G., 1985.
Choroid plexus carcinoma. Report of a case with cytopathologic differential diagnosis. Acta Cytol 29, 846–849.
[21] Krutilkova, M., Fleitz, J., Gregor, V., Novotna, K., Krepelova, A., et al., 2005.
Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer 41, 1597–1603.
[22] Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W., Kleihues, P., 2007.
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 (2), 97–109.
[23] Paulus, W., Janisch, W., 1990.
Clinicopathologic correlations in epithelial choroid plexus neoplasms: a study of 52 cases. Acta Neuropathol 80, 636–641.
[24] Russell, D.S., Rubinstein, L.J., 1971.
Pathology of tumours of the nervous system, 3rd ed. Edward Arnold, London, pp. 163–6.
[25] Shuangshoti, S., Tangchai, P., Netsky, M.G., 1971.
Primary adenocarcinoma of choroid plexus. Arch Pathol 91, 101–106. [26] St Clair, S.K., Humphreys, R.P., Pillay, P.K., Hoffman, H.J.,
Blaser, S.I., Becker, L.E., 1991.
Current management of choroid plexus carcinoma in children. Pediatr Neurosurg 17, 225–233.
[27] Uchiyama, C.M., Carey, C.M., Cherny, W.B., Brockmeyer, D.L., Falkner, L.D., Walker, M.L., et al., 1997.
Choroids plexus papilloma and cysts in the Aicardi syndrome: case report. Pediatr Neurosurg 27, 100–104.
[28] Valladares, J.B., Perry, R.H., Kalbag, R.M., 1980.
Malignant choroid plexus papilloma with extraneural metastasis. Case report. J Neurosurg. 52, 251–255.
[29] Vinchon, M., Dhellemmes, P., 2000.
Particularitée pédiatriques des tumeurs du troisième ventricule. Neurosurgery 46, 323–334.
[30] Ellenbogen RG, Winston KR, Kupsky WJ (1989)
Tumors of the choroid plexus in children. Neurosurgery 25 :327-335. [31] Ausmann JI, shrontz C, Chason J et al (1984)
Aggressive choroid plexus papilloma. Surg Neurol 22 :472-476.
[32] Uchiyama, C.M., Carey, C.M., Cherny, W.B., Brockmeyer, D.L., Falkner, L.D., Walker, M.L., et al., 1997.
Choroids plexus papilloma and cysts in the Aicardi syndrome: case report. Pediatr Neurosurg 27, 100–104.
[33] Carrea R, Polak M (1977)
Preoperative radiotherapy in the management of posterior fossa choroid plexus papillomas.Child’s Brain 3 :12-24.
[34] Wolff JEA, Sajedi M, Coppes MJ et al (1999)
Radiation therapy and survival in choroid plexus carcinoma Lancet 353 :21-26.
[35] Sandrini R, Ribero RC, DeLacerda L (1997)
Chilhood adrenocortical tumors. J Clin Endocrinol Metab 82 :2027-2031.
[36] Vital A, Bringuier PP, Huang H et al (1998)
Astrocytomas and choroids plexus tumors in two families with identical p53 germline mutations. J Neuropathol Exp Neuro 57 :1061-1069. [37] Wang L, Cornford ME (2002)
Coincidental choroid plexus carcinoma and andrenocortical carcinoma with elevated p53 expression : a case report of a 18-month-old-boy with no family history of cancer. Arch Pathol Lab Med 126 :70-72. [38] Texte rédigé par le Service d’Endocrinologie, hôpital Cochin
Centre Expert National des Cancers Rares de la Surrénale et l’Association « Surrénales » septembre 2015 ©.
[39] Chapuis Y, Azoulay D, Louvel A, Sauvanet A, Icard PH.
Incidentalomes surrénaliens. Réflexion à propos de 34 cas opérés. Sem Hop 1991;67:427–32.
[40] Sean P, Hedican, Fray F, Marshall.
Adrenocortical carcinoma with intracaval extension. J Urol 1997;158:2056–61.
[41] Michalkiewicz E, Sandrini R, Figueiredo B et al (2004)
Clinical and outcome characteristics of children with adrenocortical tumors : a report from the International pediatric Adrenocortical Tumors Registry. J Clin Oncol 22 :838-845.
[42] Ribeiro RC, Figueiredo B (2004)
Chilhood adrenocortical tumors. Eur J Cancer 40 :1117-1126. [43] Sandrini R, Ribero RC, DeLacerda L (1997)
Chilhood adrenocortical tumors. J Clin Endocrinol Metab 82 :2027-2031.
[44] Vital A, Bringuier PP, Huang H et al (1998)
Astrocytomas and choroids plexus tumors in two families with identical p53 germline mutations. J Neuropathol Exp Neurol 57 :1061-1069. [45] Wang L, Cornford ME (2002)
Coincidental choroid plexuscarcinoma and adrenocortical carcinoma with elevated p53 expression : a case report of a 18-month-old boy with no family history of cancer. Arch pathol Lab Med 126 :70-72.
[46] Russell-Swetek A, West AN, Mintern JE et al (2008)
Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma. J Med Genet 45 :603-606.
[47] Varley JM, McGown G, Thorncroft M, James LA, Margison GP, Forster G, Evans DG, Harris M, Kelsey AM, Birch JM.
Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet 1999;65:995–1006.
[48] Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G, Cat I, Stratakis CA, Sandrini R.
An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Nat Acad Sci USA 2001;98:9330–35.
[49] Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M.
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007;28:622–9.
[50] Anderson P, David D et al,
Teratomas of the head and neck region. Journal of cranio-Maxillofacial Surgery.2003 ;31 : 369-77.
[51] Stilianos E et al.
Teratomas of the head and neck. American journal of Otolaryngology.1994 ; 15 (4) : 292-6.
[52] Benouaichea L, Coulya G.
Diagnostic et prise en charge des tératomes cervico-faciaux congénitaux : à propos de quatre cas, revue de la littérature et mise au point. Annales de chirurgie plastique esthétique.2007;52 :114-23.
[53] Celik M et al. Congenital teratoma of the tongue
A case report and review of the literature. Journal of Pediatric Surgey.2006 ; 41 : 25-8.
[54] Beltaief N, Kharrat S et al.
Le tératome de la parotide : a propos de trois cas. Journal tunisien d’ORL. 200.13/52-4.
[55] Stilianos E et al.
Teratomas of the head and neck.
American Journal of Otolaryngology. 1994 ; 15 (4) : 292-6. [56] Daghfous Ellouz M.
le tératome de la parotide, une affection exceptionnelle. J of Radiologie.1987 ; 12.
[57] Cécile Faure-Conter, Nathalie Rocourt, Hélène Sudour-Bonnange, Cécile Vérité, Hélène Martelli, Catherine Patte, Didier Frappaz, Daniel Orbach.
Les tumeurs germinales de l’enfant, Bulletin du Cancer, Volume 100, Issue 4, April 2013, Pages 381-391.
[58] Ishimoto H, Jaffe RB.
Development and Function of the Human Fetal Adrenal Cortex: A Key Component in the Feto-Placental Unit.
Endocr Rev. juin 2011;32(3):317-55.
[59] Gomes DC, Leal LF, Mermejo LM, Scrideli CA, Martinelli CE, Fragoso MCBV, et al.
Sonic hedgehog signaling is active in human adrenal cortex development and deregulated in
[60] Faria AM, Almeida MQ.
Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
Mol Cell Endocrinol. 31 mars 2012;351(1):52-7.
[61] Ribeiro RC, Michalkiewicz EL, Figueiredo BC, DeLacerda L, Sandrini F, Pianovsky MD, et al.
Adrenocortical tumors in children.
Braz J Med Biol Res Rev Bras Pesqui Médicas E Biológicas Soc Bras Biofísica Al. oct 2000;33(10):1225-34.
[62] Ribeiro RC, Pinto EM, Zambetti GP.
Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies.
Best Pract Res Clin Endocrinol Metab. juin 2010;24(3):477-90. adrenocortical tumors.
[63] Malkin D.
Li-fraumeni syndrome.
Genes Cancer. avr 2011;2(4):475-84.
[64] Michalkiewicz E, Sandrini R, Figueiredo B, Miranda ECM, Caran E, Oliveira-Filho AG, et al.
Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
J Clin Oncol Off J Am Soc Clin Oncol. 1 mars 2004;22(5):838-45. [65] Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA, Malkin D.
High frequency of germline p53 mutations in childhood adrenocortical cancer.
J Natl Cancer Inst. 16 nov 1994;86(22):1707-10.
[66] Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, et al.
An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.
Proc Natl Acad Sci U S A. 31 juill 2001;98(16):9330-5.
[67] Teinturier C, Brugières L, Lemerle J, Chaussain JL, Bougnères PF. [Adrenocortical carcinoma in children: retrospective study of 54 cases].
[68] Benaily M, Schweisguth O, Job JC. [Corticosuprarenaloma in children].
Arch Fr Pédiatrie. mai 1975;32(5):441-53.
[69] Lefevre M, Gerard-Marchant R, Gubler JP, Chaussain JL, Lemerle J. Adrenal Cortical Carcinoma in Children: 42 Patients Treated from 1958 to 1980 at Villejuif. In: M.D GBH, Grindey DGB, Dehner DLP, Acton RT, Pysher DTJ, éditeurs.
Adrenal and Endocrine Tumors in Children [Internet]. Springer US; 1983 [cité 19 nov 2014]. p. 265- 76. Disponible sur: http://link.springer.com/chapter/10.1007/978-1-4613-3891-8_11
[70] McAteer JP, Huaco JA, Gow KW.
Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study. J Pediatr Surg. mai 2013;48(5):1025-31.
[71] Klein JD, Turner CG, Gray FL, Yu DC, Kozakewich HP, Perez-Atayde AR, et al.
Adrenal cortical tumors in children: factors associated with poor outcome.
J Pediatr Surg. juin 2011;46(6):1201-7. [72] Ribeiro RC, Figueiredo B.
Childhood adrenocortical tumours.
[73] Aubert S, Buob D, Leroy X, Devos P, Carnaille B, Do Cao C, et al. [Weiss system: a still in-use diagnostic tool for the assessment of adrenocortical malignancy].
Ann Pathol. déc 2005;25(6):545-54. [74] Stewart JN, Flageole H, Kavan P.
A surgical approach to adrenocortical tumors in children: the mainstay of treatment.
J Pediatr Surg. mai 2004;39(5):759-63. [75] Sandrini R, Ribeiro RC, DeLacerda L.
Childhood adrenocortical tumors.
J Clin Endocrinol Metab. juill 1997; 82 (7) :2027-31.
[76] Almeida MQ, Fragoso MCBV, Lotfi CFP, Santos MG, Nishi MY, Costa MHS, et al.
Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. J Clin Endocrinol Metab. sept 2008;93(9):3524-31.
[77] Haluska P, Worden F, Olmos D, Yin D, Schteingart D, Batzel GN, et al.
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma. Cancer Chemother Pharmacol. mars 2010;65(4):765-73.
[78] Ribeiro RC, Pinto EM, Zambetti GP, Rodriguez-Galindo C.
The International Pediatric Adrenocortical Tumor Registry initiative: contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors.
Mol Cell Endocrinol. 31 mars 2012;351(1):37-43. [79] Wieneke JA, Thompson LDR, Heffess CS.
Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients.
Am J Surg Pathol. juill 2003;27(7):867-81.
[80] Dall’Igna P, Virgone C, De Salvo GL, Bertorelle R, Indolfi P, De Paoli A, et al.
Adrenocortical tumors in Italian children: analysis of clinical characteristics and P53 status. Data from the national registries.
J Pediatr Surg. sept 2014;49(9):1367-71.
[81] Bugg MF, Ribeiro RC, Roberson PK, Lloyd RV, Sandrini R, Silva JB, et al.
Correlation of pathologic features with clinical outcome in pediatric adrenocortical neoplasia. A study of a Brazilian population. Brazilian Group for Treatment of Childhood Adrenocortical Tumors.
Am J Clin Pathol. mai 1994;101(5):625-9.
[82] Ribeiro RC, Sandrini Neto RS, Schell MJ, Lacerda L, Sambaio GA, Cat I. Adrenocortical carcinoma in children: a study of 40 cases. J Clin Oncol Off J Am Soc Clin Oncol. janv 1990;8(1):67-74.
[83] Celik M, Akkaya H, Arda IS, et al.
Congenital teratoma of the tongue: a case report and review of the literature. J Pediatr Surg 2006;41:e25–8.
[84] Azizkhan RG, Caty MG.
Teratomas in childhood. Curr Opin Pediatr 1996;8:287–92. [85] BOURRILLON A
Pédiatrie. 3ème Ed MASSON p424-246-310. [86] CABANNE F, BONENFANT J.L
Anatomie pathologique. Principe de pathologie générale, de pathologie spéciale et d’aetopathologie. 2ème édition, Maloine, Paris. 1986 ; 1490p.
[87] DALLE J-H
Particularités épidémiologiques, diagnostiques et thérapeutiques des principaux cancers de l’enfant. La collection Hippocrate (servier). 2005 ; 1-10-144, 11p.
[88] DESANDES E, CLAVEL J, BERGER C, et Coll.
Cancer incidence among children in France, 1990–1999. Pediatr Blood Cancer 2004; 43:749–57.